Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells.
about
Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidenceExtra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton.Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4Deep sequencing reveals new aspects of progesterone receptor signaling in breast cancer cellsNatural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro.Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude miceProgestin upregulates G-protein-coupled receptor 30 in breast cancer cells.Diethylstilboestrol for the treatment of prostate cancer: past, present and future.Systems pharmacology of mifepristone (RU486) reveals its 47 hub targets and network: comprehensive analysis and pharmacological focus on FAK-Src-Paxillin complex.Apigenin prevents development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats.Alternative splicing of VEGFA, APP and NUMB genes in colorectal cancerReversal of multidrug resistance in drug-resistant human gastric cancer cell line SGC7901/VCR by antiprogestin drug mifepristone.Effects of mifepristone on invasive and metastatic potential of human gastric adenocarcinoma cell line MKN-45 in vitro and in vivo.Vascular endothelial growth factor and breast cancer risk.The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor developmentEstrogen regulation of thrombospondin-1 in human breast cancer cells.Inhibition of vascular endothelial growth factor receptor signal transduction blocks follicle progression but does not necessarily disrupt vascular development in perinatal rat ovaries.Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumors.Slit protein-mediated inhibition of CXCR4-induced chemotactic and chemoinvasive signaling pathways in breast cancer cells.Cholesterol biosynthesis inhibitor RO 48-8071 reduces progesterone receptor expression and inhibits progestin-dependent stem cell-like cell growth in hormone-dependent human breast cancer cellsThe role of steroid hormones on the regulation of vascular endothelial growth factor.Non-competitive steroid inhibition of oestrogen receptor functions.
P2860
Q24647700-2A44EE01-6A0E-48B1-916C-F25CBDE93CEBQ33355956-BB816FA4-9F36-44A0-ACBE-D289A0D082B8Q33584212-794DF432-B4A0-429D-8535-A8E3E6670BF0Q33711732-4FBA7541-437C-45B0-90FB-BFAAC2090F9BQ33734466-C6C2D228-3116-4946-816A-4E300D4CF948Q34071824-4E0896E7-844A-48BE-9D16-9F6CF96B206DQ34129948-23F53F30-B642-46A8-B4F3-4DA07465005EQ34386403-1D8A0A26-AB60-42FC-8BCF-4ECED686CAEFQ34981020-2C4F7E7E-B74A-4C6C-9311-ACEB1676ED0EQ35150939-BDFCD44C-6DFC-43D6-B0BC-9E6684D5859BQ35692268-82F708E4-0300-4041-8AC3-1F867B748D85Q36065946-3FA3CB87-919B-466F-A9C1-61C7686B796CQ36065949-F0C554E8-8855-41D2-9E6B-BE2B7362DE1AQ36619082-1B3EAB3B-F0E3-49A1-8BDB-C6AB2A4D351EQ36642960-7E198BAC-9EF3-4515-8C5F-E20E85EAECC5Q37371384-0D0619BA-95C2-40B6-9EAF-D4E2E19B0C41Q37404743-F13CC917-F059-454A-8F21-5353ABA0AD57Q39351791-580D8313-AFCB-4173-878A-B008D03F2342Q40612882-3742002D-B3D0-47FE-9525-0845291A81C5Q41018669-59A04A14-35ED-4E25-B6F2-724B17D8AACDQ42855909-070BDEA4-3B57-4DBC-BB0E-2EC62CB95A85Q44124083-8C5B05D7-62A4-457F-97D2-5A52E5759691
P2860
Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Pharmacological and endogenous ...... in human breast cancer cells.
@en
Pharmacological and endogenous ...... in human breast cancer cells.
@nl
type
label
Pharmacological and endogenous ...... in human breast cancer cells.
@en
Pharmacological and endogenous ...... in human breast cancer cells.
@nl
prefLabel
Pharmacological and endogenous ...... in human breast cancer cells.
@en
Pharmacological and endogenous ...... in human breast cancer cells.
@nl
P2093
P2860
P356
P1476
Pharmacological and endogenous ...... in human breast cancer cells.
@en
P2093
C Chiappetta
G M Stancel
P2860
P304
P356
10.1002/IJC.1236
P577
2001-05-01T00:00:00Z